Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Retained EarningsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming (PHAR) Total Debt (2019 - 2022)

Historic Total Debt for Pharming (PHAR) over the last 4 years, with Q3 2022 value amounting to $143000.0.

  • Pharming's Total Debt fell 6358.57% to $143000.0 in Q3 2022 from the same period last year, while for Sep 2022 it was $143000.0, marking a year-over-year decrease of 6358.57%. This contributed to the annual value of $165875.8 for FY2021, which is 5801.18% down from last year.
  • Per Pharming's latest filing, its Total Debt stood at $143000.0 for Q3 2022, which was down 6358.57% from $152000.0 recorded in Q2 2022.
  • Pharming's 5-year Total Debt high stood at $38.9 million for Q4 2019, and its period low was $143000.0 during Q3 2022.
  • Moreover, its 4-year median value for Total Debt was $191479.2 (2021), whereas its average is $4.5 million.
  • As far as peak fluctuations go, Pharming's Total Debt tumbled by 9893.87% in 2020, and later crashed by 1658.26% in 2022.
  • Quarter analysis of 4 years shows Pharming's Total Debt stood at $38.9 million in 2019, then plummeted by 98.94% to $412532.3 in 2020, then tumbled by 59.79% to $165875.8 in 2021, then decreased by 13.79% to $143000.0 in 2022.
  • Its last three reported values are $143000.0 in Q3 2022, $152000.0 for Q2 2022, and $162000.0 during Q1 2022.